Apellis Pharmaceuticals, Inc. (APLS)
Apellis Pharmaceuticals, Inc. filed 14 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 16 transactions and 340,095 shares. 3 carry the SEC's AFF10B5ONE flag; 11 name a plan only in a footnote. 2 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2025-12-18, came 30 days after the one before it (2025-11-18) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 5,000 shares, the same as the 5,000 in the filing before it.
- Its 14 plan statements rank 335th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 14 filings on file run from 2025-06-18 to 2025-12-18, and state one plan adoption date, 2025-06-20.
Trades in Apellis Pharmaceuticals, Inc. 16
- Watson David O. — 2025-06-16 · S · 5,000 shares
- Francois Cedric — 2025-07-14 · S · 137,465 shares
- Francois Cedric — 2025-07-15 · S · 1,900 shares
- Watson David O. — 2025-07-16 · S · 5,000 shares
- Francois Cedric — 2025-07-17 · S · 19,725 shares
- Watson David O. — 2025-08-18 · S · 5,000 shares
- Sullivan Timothy Eugene — 2025-09-08 · S · 32,729 shares
- Sullivan Timothy Eugene — 2025-09-08 · S · 10,000 shares
- Watson David O. — 2025-09-16 · S · 5,000 shares
- Dunlop A. Sinclair — 2025-09-19 · S · 31,092 shares
- Dunlop A. Sinclair — 2025-09-30 · S · 31,092 shares
- Dunlop A. Sinclair — 2025-10-10 · S · 31,092 shares
Adoption dates in Apellis Pharmaceuticals, Inc. 1
- 2025-06-20 — stated in 3 filings
Results prints in Apellis Pharmaceuticals, Inc. 2
- 2025-01-13
- 2026-01-12
Trades before a print in Apellis Pharmaceuticals, Inc. 0
- 27 days before the 2026-01-12 print — 2025-12-16 · S · Watson David O. · 5,000 shares
- 56 days before the 2026-01-12 print — 2025-11-17 · S · Watson David O. · 5,000 shares
- 83 days before the 2026-01-12 print — 2025-10-21 · S · Sullivan Timothy Eugene · 10,000 shares
- 88 days before the 2026-01-12 print — 2025-10-16 · S · Watson David O. · 5,000 shares
- 94 days before the 2026-01-12 print — 2025-10-10 · S · Dunlop A. Sinclair · 31,092 shares
- 104 days before the 2026-01-12 print — 2025-09-30 · S · Dunlop A. Sinclair · 31,092 shares
- 115 days before the 2026-01-12 print — 2025-09-19 · S · Dunlop A. Sinclair · 31,092 shares
- 118 days before the 2026-01-12 print — 2025-09-16 · S · Watson David O. · 5,000 shares
- 126 days before the 2026-01-12 print — 2025-09-08 · S · Sullivan Timothy Eugene · 32,729 shares
- 126 days before the 2026-01-12 print — 2025-09-08 · S · Sullivan Timothy Eugene · 10,000 shares
- 147 days before the 2026-01-12 print — 2025-08-18 · S · Watson David O. · 5,000 shares
- 179 days before the 2026-01-12 print — 2025-07-17 · S · Francois Cedric · 19,725 shares
Interval to Apellis Pharmaceuticals, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 27shortest, days
- 0no later print
Adoption dates Apellis Pharmaceuticals, Inc. states
- 2025-06-20 in 3 filings
Filing text: “10b5-1 trading plan adopted by Epidarex Capital I LP ("Epidarex") on June 20, 2025”
Reported results dates on file
- 2025-01-13
- 2026-01-12
A proxy statement is on file for this company in the same window (2025-04-23), which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
Apellis Pharmaceuticals, Inc.’s insider trading plan record — 14 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001492422.